Profilo
John J.
Koleng is the founder of Alphavektor LLC, which was founded in 2008.
Dr. Koleng is also the founder of Axxis Innovations, Inc. Dr. Koleng's current job is Vice President-Product Development & Manufacturing at TFF Pharmaceuticals, Inc. Dr. Koleng is also a founding member at Via Therapeutics LLC and Cloxero Therapeutics, Inc. Dr. Koleng's former jobs include being a VP-Industrial Operations & Founding Member at Formulation Technologies LLC and a founding member at Oticara, Inc. Dr. Koleng completed his undergraduate degree in 1994 and his doctorate degree in 2002 at The University of Texas at Austin.
Posizioni attive di John J. Koleng
| Società | Posizione | Inizio |
|---|---|---|
| TFF PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Via Therapeutics LLC | Corporate Officer/Principal | - |
Cloxero Therapeutics, Inc. | Corporate Officer/Principal | - |
Precedenti posizioni note di John J. Koleng
| Società | Posizione | Fine |
|---|---|---|
Formulation Technologies LLC
Formulation Technologies LLC Medical/Nursing ServicesHealth Services Delivers drug product solutions that help clients reduce development costs and accelerate time-to-market | Direttore operativo | - |
Axxis Innovations, Inc. | Fondatore | - |
Oticara, Inc.
Oticara, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that helps chronic rhinosinusitis | Corporate Officer/Principal | - |
Alphavektor LLC | Fondatore | - |
Formazione di John J. Koleng
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Formulation Technologies LLC
Formulation Technologies LLC Medical/Nursing ServicesHealth Services Delivers drug product solutions that help clients reduce development costs and accelerate time-to-market | Health Services |
TFF Pharmaceuticals, Inc.
TFF Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures inhaled dry powder drugs for the treatment of pulmonary diseases and conditions | Health Technology |
Alphavektor LLC | |
Oticara, Inc.
Oticara, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that helps chronic rhinosinusitis | Health Technology |
Axxis Innovations, Inc. | |
Via Therapeutics LLC | |
Cloxero Therapeutics, Inc. |
















